Apathy Associated with Lower Quality of Life in ALS Patients, Study Shows
Amyotrophic lateral sclerosis (ALS) patients experiencing feelings of apathy reported lower quality of life (QoL), particularly regarding achievements in life…
Articles by José Lopes, PhD
Naturally Occurring Enzyme Improves ALS Symptoms in Mice, Study Shows
A naturally occurring enzyme improves ALS symptoms in mice and could lead to effective therapies in humans, a study suggests.
University of Michigan Develops New Model for Predicting ALS Patients’ Survival
A new model for predicting ALS patients’ survival looks promising, University of Michigan researchers report. In fact, it want a…
Bioequivalence Study of Sublingual BHV-0223 Shows Positive Results as Rilutek Substitute
A dissolving tablet version of riluzole called BHV-0223 has shown positive bioequivalence when compared to the oral form of the therapy,…
Canada’s NeuroSGC Partnership Seeks Potential Treatments for ALS, Parkinson’s Disease
NeuroSGC, a new scientific partnership formed by the Structural Genomics Consortium (SGC) and the Montreal Neurological Institute and…
Repeated Trauma to Head or Body, Especially at Midlife, Raise Risk of ALS, Study Finds
Repeated severe trauma to the body or mild injuries to the head — especially at midlife — raise a person’s…
Shorter ALS Survival Found for US World War II Vets or Those Who Handled Burning Agents
Military veterans in the United States who were deployed to World War II or who handled burning agents during their…
Long-term Air Pollution Increases People’s Susceptibility to ALS, Dutch Study Finds
Long-term exposure to air pollution increases the risk of a person developing amyotrophic lateral sclerosis, a Dutch study shows. The…
Decreased Ability in Finding One’s Way Could Help Diagnose Dementia in ALS or Alzheimer’s, Study Suggests
Measuring changes in how humans find their way could enable earlier diagnosis of dementia in neurodegenerative diseases, such as…
Disarm Therapeutics Receives Key Funding for ALS Therapy Development
Research into the development of new therapies to treat several traumatic, inflammatory, and neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) received…